单介绍
CCL-2.2 HelaS3 人宫颈癌细胞 的详细介绍
CCL-2.2 HelaS3 人宫颈癌细胞
ATCC® Number: | CCL-2.2™ | Price: | ||||||||||||||||||||||||
|
Isolation: | Isolation date: 1955 |
Applications: | transfection host (Roche FuGENE® Transfection Reagents technology from amaxa) |
Virus Susceptibility: | poliovirus 1, 2, 3; vesicular stomatitis (Indiana); encephalomyocarditis; adenovirus 5 |
Reverse Tran |
negative |
DNA Profile (STR): | Amelogenin: X CSF1PO: 9,10 D13S317: 13.3 D16S539: 9,10 D5S818: 11,12 D7S820: 8,12 THO1: 7 TPOX: 8,12 vWA: 16,18 |
Cytogenetic Analysis: | A medium-sized metacentric marker is present in 100% of the cells. HeLa Markers: One copy of M1, one copy of M2, two copies of M3, and one copy of M4. |
Isoenzymes: | G6PD, A |